SAM
COLL icon

Shell Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Shell Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$76K Sell
2,166
-2,992
-58% -$104K 0.01% 730
2025
Q2 		$153K Sell
5,158
-1,244
-19% -$35.5K 0.01% 855
2025
Q1 		$191K Sell
6,402
-159
-2% -$4.86K 0.01% 812
2024
Q4 		$188K Hold
6,561
– – 0.01% 859
2024
Q3 		$254K Buy
+6,561
New +$234K 0.01% 742
2024
Q1 		$223K Sell
6,930
-722
-9% -$25.3K 0.01% 777
2023
Q4 		$236K Sell
7,652
-2,327
-23% -$58.3K 0.01% 793
2023
Q3 		$223K Sell
9,979
-156
-2% -$3.56K 0.01% 867
2023
Q2 		$218K Sell
10,135
-56
-0.5% -$1.27K 0.01% 888
2023
Q1 		$244K Sell
10,191
-36
-0.4% -$955 0.01% 862
2022
Q4 		$237K Sell
10,227
-2,086
-17% -$42.1K 0.01% 879
2022
Q3 		$197K Sell
12,313
-3,241
-21% -$57.2K 0.01% 1017
2022
Q2 		$276K Buy
15,554
+6,121
+65% +$103K 0.01% 1015
2022
Q1 		$192K Sell
9,433
-1,395
-13% -$26.4K ﹤0.01% 1168
2021
Q4 		$202K Buy
10,828
+51
+0.5% +$994 ﹤0.01% 1206
2021
Q3 		$213K Sell
10,777
-460
-4% -$9.95K ﹤0.01% 1185
2021
Q2 		$266K Buy
11,237
+7,040
+168% +$163K 0.01% 1157
2021
Q1 		$99K Buy
+4,197
New +$99.7K ﹤0.01% 1289

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Shell Asset Management's COLL Position: Q3 2025 in Review

Shell Asset Management reduced its Collegium Pharmaceutical (COLL) stake by 58% in Q3 2025, selling an estimated $104K and leaving 2,166 shares worth $76K. The position accounts for 0.01% of the portfolio, ranked #730.

Shell Asset Management first reported a position in COLL in Q1 2021 and has held it in 18 quarters since. The position peaked at $276K in Q2 2022. 244 funds tracked by Wall St. Rank hold COLL as of Q3 2025.

  • Shell Asset Management held 2,166 shares of Collegium Pharmaceutical worth $76K as of Q3 2025.
  • Shell Asset Management sold 2,992 Collegium Pharmaceutical shares in Q3 2025, an estimated $104K.
  • Collegium Pharmaceutical made up 0.01% of Shell Asset Management's portfolio in Q3 2025, its #730 holding.
  • Shell Asset Management first reported a position in Collegium Pharmaceutical in Q1 2021 and has held it in 18 quarters since.
  • Shell Asset Management's Collegium Pharmaceutical position peaked at $276K in Q2 2022.
  • 244 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.